Home Data Calendar Blog

ATNX

Tables

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Common Stock Value		0.01	0.16	0.12	0.11	0.11	0.11	0.11	0.10	0.10	0.10	0.08	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.06	0.06	0.06	NA	0.04	NA	NA	NA
Weighted Average Number Of Diluted Shares Outstanding		NA	139.47	113.01	NA	NA	109.29	103.37	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic		NA	139.47	113.01	NA	NA	109.29	103.37	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Share Outstanding Basic And Diluted		NA	NA	NA	110.50	NA	109.29	103.37	93.43	NA	83.71	81.56	81.54	NA	77.30	73.11	67.01	NA	66.40	63.31	61.66	NA	57.13	43.74	40.69	NA	40.26	39.78	NA
Earnings Per Share Basic		-15.24	-0.14	-0.28	NA	-37.51	-0.33	-0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		-15.24	-0.14	-0.28	NA	-37.51	-0.33	-0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Basic And Diluted		NA	NA	NA	-0.16	-0.99	-0.33	-0.33	-0.27	-0.53	-0.44	-0.50	-0.24	-0.28	-0.45	-0.44	-0.53	-0.41	-0.70	-0.58	-0.12	-0.49	-0.41	-0.88	-1.01	-0.98	-0.61	-0.31	-0.27
Income Loss From Continuing Operations Per Basic Share		-0.00	-0.00	-0.00	NA	-0.00	-0.00	-0.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Income Loss From Continuing Operations Per Diluted Share		-0.00	-0.00	-0.00	NA	-0.00	-0.00	-0.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Revenue From Contract With Customer Excluding Assessed Tax		8.63	33.53	31.52	29.72	24.94	32.30	21.92	41.02	21.81	35.48	40.17	46.94	34.36	19.36	22.20	25.31	21.27	18.43	11.56	37.84	14.87	13.99	4.59	4.58	5.11	5.62	5.19	4.63
Revenues		8.63	33.53	31.52	29.72	24.94	32.30	21.92	41.02	21.81	35.48	40.17	46.94	34.36	19.36	22.20	25.31	21.27	18.43	11.56	37.84	14.87	13.99	4.59	4.58	5.11	5.62	5.19	4.63
Cost Of Goods And Services Sold		2.46	27.74	23.09	23.30	20.69	25.64	19.66	16.41	18.27	24.51	33.01	19.57	15.70	17.07	16.94	19.90	14.27	11.96	9.44	11.33	10.06	8.08	4.14	2.84	NA	NA	NA	NA
Gross Profit		6.17	5.79	8.42	6.43	4.24	6.65	2.26	24.62	3.54	10.97	7.17	27.36	18.66	2.29	5.25	5.41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating Expenses		19.91	18.65	30.27	28.93	94.10	40.52	42.36	45.19	49.71	40.61	39.50	42.94	39.93	35.87	35.68	39.66	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Research And Development Expense		15.37	9.21	13.09	13.99	18.27	17.73	21.13	23.07	18.31	18.39	22.02	17.19	21.82	19.59	18.51	24.48	20.83	51.20	26.57	21.30	20.85	11.94	17.60	26.41	27.18	18.05	8.64	6.75
Selling General And Administrative Expense		4.46	9.44	17.17	14.94	6.41	22.79	21.23	22.12	31.40	22.22	17.49	25.75	18.11	16.28	17.17	15.19	11.62	11.49	12.82	13.08	12.32	10.36	13.63	9.80	10.26	6.79	4.57	4.34
Operating Income Loss		-13.73	-12.86	-21.84	-22.50	-89.85	-33.87	-40.10	-20.57	-46.17	-29.64	-32.34	-15.58	-21.27	-33.58	-30.42	-34.26	-25.45	-56.23	-37.27	-7.87	-28.36	-16.40	-30.77	-34.47	-37.66	-24.64	-12.85	-10.60
Interest Expense		10.75	6.27	4.31	4.52	5.05	5.10	5.68	4.91	4.39	3.60	1.56	1.67	1.70	1.75	1.75	1.75	1.80	1.71	NA	NA	-0.10	0.35	3.28	NA	1.88	0.01	0.05	NA
Interest Paid Net		1.32	2.06	3.91	3.79	12.62	0.00	0.01	7.71	2.98	0.00	1.69	1.39	0.51	1.94	1.49	0.98	2.02	NA	NA	0.01	NA	NA	NA	NA	NA	NA	NA	NA
Gains Losses On Extinguishment Of Debt		-1.68	0.00	2.05	-3.50	0.00	0.00	NA	NA	0.00	-3.05	-7.23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		1.44	1.42	1.60	1.89	1.88	2.65	2.44	2.28	2.61	2.86	3.05	2.33	2.58	2.23	3.30	1.78	2.35	2.42	3.54	2.70	2.88	2.89	6.68	2.15	9.34	4.12	3.13	NA
Income Loss From Continuing Operations		-25.78	-19.62	-24.03	-30.47	-106.36	-34.83	-31.25	-24.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Income Tax Expense Benefit		-0.26	0.60	-0.02	0.03	0.01	0.26	-11.04	0.15	0.01	1.09	0.11	2.88	-0.09	0.11	0.41	0.50	0.39	-0.03	0.05	-0.31	0.14	0.01	0.03	-0.09	0.03	0.01	-0.40	NA
Profit Loss		-34.25	-19.87	-32.37	-17.93	-105.08	-36.74	-34.62	-25.60	-50.40	-37.27	-41.05	-19.72	-22.41	-34.79	-32.10	-36.23	-27.16	-57.26	-36.95	-7.34	-28.39	-23.31	-38.67	-41.02	-40.10	-24.66	-12.50	-10.65
Other Comprehensive Income Loss Net Of Tax		NA	1.52	1.40	0.56	NA	0.09	-0.28	0.29	NA	0.04	0.07	-0.51	NA	-0.31	-0.53	1.07	-0.04	-0.59	-0.57	0.68	0.27	0.25	0.14	0.50	-0.67	-0.05	NA	NA
Net Income Loss		-34.18	-19.67	-32.16	-17.42	-104.39	-36.06	-34.27	-25.05	-49.49	-36.81	-40.45	-19.43	-21.73	-34.76	-32.03	-35.23	-27.11	-46.17	-36.86	-7.30	-28.28	-23.27	-38.62	-40.99	-40.05	-24.62	-12.42	-10.62
Comprehensive Income Net Of Tax		-36.28	-18.15	-30.76	-16.86	-103.84	-35.97	-34.56	-24.76	-49.60	-36.77	-40.38	-19.93	-21.94	-35.07	-32.56	-34.16	-27.15	-46.76	-37.42	-6.62	-28.02	-23.03	-38.48	-40.49	-40.72	-24.67	-12.75	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Assets		204.06	228.35	221.89	236.86	267.45	385.89	408.96	349.66	384.33	409.64	298.05	297.79	309.93	287.60	322.27	220.31	231.09	244.47	177.29	197.53	140.41	148.76	157.81	NA	105.89	NA	NA	NA
Liabilities		228.24	221.11	227.36	216.06	233.00	250.01	239.08	206.53	218.98	197.41	171.81	139.55	134.08	152.77	155.07	124.73	102.33	92.41	52.88	41.45	49.69	33.86	37.44	NA	71.22	NA	NA	NA
Liabilities And Stockholders Equity		204.06	228.35	221.89	236.86	267.45	385.89	408.96	349.66	384.33	409.64	298.05	297.79	309.93	287.60	322.27	220.31	231.09	244.47	177.29	197.53	140.41	148.76	157.81	NA	105.89	NA	NA	NA
Stockholders Equity		-6.51	24.84	11.94	37.99	51.13	151.88	185.20	158.10	179.78	225.76	139.31	170.90	188.22	146.51	178.86	107.16	139.35	162.59	123.86	155.44	90.04	114.10	119.54	NA	33.81	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Assets Current		124.93	126.71	117.75	131.59	133.40	184.84	213.09	251.15	291.96	324.20	216.61	217.90	230.93	213.54	249.69	150.68	170.82	187.70	119.55	140.09	83.76	93.01	102.32	NA	51.92	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		30.44	35.19	22.14	27.22	35.20	73.59	76.94	47.98	69.59	143.56	105.90	71.98	127.67	61.48	96.73	71.00	49.79	51.11	14.07	39.22	39.28	19.26	55.15	26.03	33.12	43.53	26.14	NA
Short Term Investments		1.07	1.03	1.19	10.23	10.21	14.92	53.28	123.19	138.64	84.75	10.41	41.72	33.14	42.27	43.72	0.34	57.63	90.31	66.59	67.26	11.75	49.78	30.15	NA	8.63	NA	NA	NA
Accounts Receivable Net Current		27.86	32.91	33.82	29.61	26.64	33.76	22.22	20.19	23.60	42.99	38.62	51.42	16.69	17.17	9.56	20.58	12.95	7.07	5.14	7.84	8.47	6.46	3.78	NA	2.78	NA	NA	NA
Inventory Net		42.65	42.04	37.85	41.25	34.69	31.58	29.77	26.32	28.85	29.61	31.14	35.73	32.63	28.45	27.24	25.19	28.79	25.23	21.80	18.57	16.56	11.63	9.26	NA	4.24	NA	NA	NA
Prepaid Expense And Other Assets Current		10.58	4.12	3.98	9.52	8.88	14.49	14.38	16.97	14.79	9.55	19.53	17.05	20.79	38.74	46.97	33.57	21.66	13.98	11.95	7.20	7.69	5.88	3.98	NA	3.15	NA	NA	NA
Machinery And Equipment Gross		2.69	NA	NA	NA	19.21	NA	NA	NA	11.35	NA	NA	NA	6.72	NA	NA	NA	6.24	NA	NA	NA	5.12	NA	NA	NA	3.96	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Property Plant And Equipment Gross		6.28	NA	NA	NA	39.69	NA	NA	NA	43.11	NA	NA	NA	29.11	NA	NA	NA	15.33	NA	NA	NA	13.24	NA	NA	NA	7.87	NA	NA	NA
Furniture And Fixtures Gross		0.07	NA	NA	NA	0.84	NA	NA	NA	0.93	NA	NA	NA	0.58	NA	NA	NA	0.64	NA	NA	NA	0.97	NA	NA	NA	0.84	NA	NA	NA
Leasehold Improvements Gross		0.69	NA	NA	NA	13.76	NA	NA	NA	2.93	NA	NA	NA	2.79	NA	NA	NA	1.38	NA	NA	NA	1.33	NA	NA	NA	0.95	NA	NA	NA
Construction In Progress Gross		0.24	NA	NA	NA	1.19	NA	NA	NA	22.51	NA	NA	NA	14.76	NA	NA	NA	3.83	NA	NA	NA	3.23	NA	NA	NA	0.67	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		4.45	NA	NA	NA	11.71	NA	NA	NA	8.72	NA	NA	NA	5.96	NA	NA	NA	3.88	NA	NA	NA	3.59	NA	NA	NA	2.06	NA	NA	NA
Amortization Of Intangible Assets		0.30	0.30	0.30	0.30	0.40	0.40	0.50	0.60	0.40	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.40	0.40	0.40	0.40	0.40	0.40	0.40	0.40	0.30	0.20	0.10	NA
Property Plant And Equipment Net		1.82	3.91	4.19	26.86	27.98	51.92	45.69	41.78	34.39	28.87	26.87	24.62	23.15	19.27	16.31	12.25	11.45	11.17	10.40	10.37	9.65	8.82	8.32	NA	5.81	NA	NA	NA
Intangible Assets Net Excluding Goodwill		72.11	72.17	72.47	71.57	71.90	73.89	72.78	9.48	10.22	9.56	8.02	8.53	8.52	8.97	9.77	10.36	10.85	7.25	7.74	8.28	8.57	8.90	9.24	NA	8.46	NA	NA	NA
Finite Lived Intangible Assets Net		6.57	NA	NA	NA	6.28	NA	NA	NA	9.69	NA	NA	NA	8.22	NA	NA	NA	10.51	NA	NA	NA	7.74	NA	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent		0.80	0.95	0.99	1.05	1.09	1.13	1.17	0.95	0.95	0.88	NA	NA	NA	NA	NA	NA	NA	NA	1.07	NA	0.19	0.33	0.33	NA	2.14	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Liabilities Current		114.88	84.90	90.17	80.78	96.05	73.53	62.92	49.70	62.14	66.55	66.91	76.80	71.53	89.97	95.31	67.75	51.68	42.10	47.75	36.63	45.14	29.84	27.10	NA	28.02	NA	NA	NA
Accounts Payable Current		33.68	25.07	21.40	16.61	16.74	22.88	19.47	15.86	18.67	14.87	15.95	18.39	23.33	16.21	15.58	20.39	13.00	12.69	14.34	16.15	16.66	6.62	7.32	NA	7.17	NA	NA	NA
Accrued Income Taxes Current		1.75	1.68	1.67	1.92	1.80	1.65	1.55	1.86	1.95	2.81	5.23	5.28	0.19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Accrued Liabilities Current		35.37	40.08	39.28	36.96	24.45	40.13	35.61	28.71	38.27	47.11	47.14	54.74	44.31	69.99	75.12	42.57	37.72	28.06	26.83	13.51	26.98	21.59	17.89	NA	18.96	NA	NA	NA
Contract With Customer Liability Current		2.82	2.79	2.78	3.28	3.29	3.21	1.08	1.29	1.15	0.33	0.10	0.07	0.22	20.07	20.16	0.13	0.19	0.36	5.53	NA	1.20	NA	NA	NA	NA	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Deferred Income Tax Liabilities Net		1.75	1.75	1.75	1.75	1.75	1.82	1.83	0.06	0.06	0.05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Minority Interest		-17.68	-17.61	-17.41	-17.19	-16.68	-16.00	-15.32	-14.98	-14.43	-13.52	-13.06	-12.66	-12.37	-11.69	-11.66	-11.58	-10.59	-10.54	0.55	0.64	0.69	0.80	0.83	NA	0.86	NA	NA	NA
Other Liabilities Noncurrent		2.73	2.71	2.69	2.87	3.05	3.32	3.50	3.67	3.85	2.63	2.61	2.58	2.56	NA	NA	NA	4.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating Lease Liability Noncurrent		3.05	3.43	3.90	4.28	4.49	4.75	5.32	5.83	6.36	6.43	6.85	7.23	7.62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Stockholders Equity		-6.51	24.84	11.94	37.99	51.13	151.88	185.20	158.10	179.78	225.76	139.31	170.90	188.22	146.51	178.86	107.16	139.35	162.59	123.86	155.44	90.04	114.10	119.54	NA	33.81	NA	NA	NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		-24.18	7.24	-5.47	20.80	34.45	135.88	169.88	143.12	165.35	212.24	126.25	158.24	175.85	134.83	167.21	95.58	128.77	152.06	124.41	156.09	90.72	114.90	120.37	-3.62	34.67	69.61	90.23	NA
Common Stock Value		0.01	0.16	0.12	0.11	0.11	0.11	0.11	0.10	0.10	0.10	0.08	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.06	0.06	0.06	NA	0.04	NA	NA	NA
Additional Paid In Capital Common Stock		1017.19	1012.11	980.82	976.12	972.40	969.32	966.67	904.95	901.86	898.25	775.04	766.25	763.65	700.00	697.28	593.03	591.06	587.15	501.66	495.82	423.81	419.85	402.27	NA	237.58	NA	NA	NA
Retained Earnings Accumulated Deficit		-1016.84	-982.66	-962.99	-930.83	-913.41	-809.02	-772.97	-738.69	-713.64	-664.15	-627.35	-586.89	-567.47	-545.74	-510.98	-478.95	-443.72	-416.60	-370.43	-333.57	-326.28	-297.99	-274.72	NA	-195.11	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		0.89	2.99	1.47	0.07	-0.49	-1.04	-1.12	-0.84	-1.13	-1.03	-1.07	-1.14	-0.64	-0.42	-0.11	0.41	-0.66	-0.62	-0.03	0.54	-0.15	-0.41	-0.66	NA	-1.30	NA	NA	NA
Treasury Stock Value		7.76	7.76	7.49	7.49	7.49	7.49	7.49	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	7.41	NA	7.41	NA	NA	NA
Minority Interest		-17.68	-17.61	-17.41	-17.19	-16.68	-16.00	-15.32	-14.98	-14.43	-13.52	-13.06	-12.66	-12.37	-11.69	-11.66	-11.58	-10.59	-10.54	0.55	0.64	0.69	0.80	0.83	NA	0.86	NA	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Net Income Loss		-34.18	-19.67	-32.16	-17.42	-104.39	-36.06	-34.27	-25.05	-49.49	-36.81	-40.45	-19.43	-21.73	-34.76	-32.03	-35.23	-27.11	-46.17	-36.86	-7.30	-28.28	-23.27	-38.62	-40.99	-40.05	-24.62	-12.42	-10.62
Profit Loss		-34.25	-19.87	-32.37	-17.93	-105.08	-36.74	-34.62	-25.60	-50.40	-37.27	-41.05	-19.72	-22.41	-34.79	-32.10	-36.23	-27.16	-57.26	-36.95	-7.34	-28.39	-23.31	-38.67	-41.02	-40.10	-24.66	-12.50	-10.65
Depreciation Depletion And Amortization		0.70	0.80	0.71	1.06	1.33	1.20	1.19	1.27	1.28	1.09	1.03	1.09	1.01	1.00	0.93	0.88	0.84	0.91	0.95	0.87	1.09	0.92	0.85	0.82	0.70	0.58	0.34	NA
Increase Decrease In Inventories		4.60	4.19	4.23	6.57	3.17	1.81	3.44	-2.52	-0.76	-1.54	-4.59	3.10	4.18	1.21	2.05	-3.60	3.56	3.43	3.23	2.01	4.93	2.38	2.42	2.60	0.02	-0.12	NA	NA
Share Based Compensation		1.44	1.41	1.60	1.87	1.88	2.65	2.44	2.23	2.85	2.69	3.05	2.26	2.66	2.15	3.30	1.78	2.35	2.42	3.54	2.70	2.88	2.89	6.67	2.15	9.34	4.13	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Payments To Acquire Property Plant And Equipment		-0.06	0.11	0.17	0.19	-8.80	6.74	3.12	7.34	6.55	2.14	2.83	1.74	5.06	3.62	3.97	0.92	0.82	0.87	0.46	1.18	1.06	0.94	1.89	1.55	0.37	0.61	NA	NA

		2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
Revenues		8.63	33.53	31.52	29.72	24.94	32.30	21.92	41.02	21.81	35.48	40.17	46.94	34.36	19.36	22.20	25.31	21.27	18.43	11.56	37.84	14.87	13.99	4.59	4.58	5.11	5.62	5.19	4.63
Revenue From Contract With Customer Excluding Assessed Tax		8.63	33.53	31.52	29.72	24.94	32.30	21.92	41.02	21.81	35.48	40.17	46.94	34.36	19.36	22.20	25.31	21.27	18.43	11.56	37.84	14.87	13.99	4.59	4.58	5.11	5.62	5.19	4.63
Kuur Therapeutics Inc, Merger Agreement		0.00	0.00	0.10	0.00	0.00	0.00	0.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Intersegment Elimination		NA	-0.35	-0.42	-1.13	-0.41	-0.34	-0.29	-1.11	-2.29	-0.50	-1.03	-0.71	-1.18	-0.73	-0.97	-0.85	-1.68	-1.10	-1.39	-1.22	-2.29	-2.19	-2.00	-2.52	-2.43	-2.27	-1.46	NA
Operating		NA	33.88	31.94	30.86	25.35	32.64	22.21	42.13	24.09	35.98	41.20	47.64	35.55	20.09	23.17	26.16	22.95	19.52	12.95	39.05	17.17	16.18	6.60	7.11	7.54	7.89	6.65	NA
Intersegment Elimination, Oncology Innovation Platform		NA	0.30	0.40	1.10	NA	0.30	0.30	0.50	NA	0.50	1.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating, Commercial Platform		20.46	24.87	19.94	22.71	16.91	21.03	15.79	13.26	16.09	21.73	36.21	15.54	12.15	12.01	11.60	14.68	7.42	7.32	7.00	8.69	7.94	7.38	1.82	0.08	NA	0.00	0.00	NA
Operating, Global Supply Chain Platform		NA	6.83	6.26	7.38	7.67	6.48	6.11	8.21	7.99	3.81	4.98	3.71	3.26	7.97	11.41	11.34	13.28	7.09	5.77	5.13	9.02	8.60	4.51	6.30	7.21	7.77	6.25	NA
Operating, Oncology Innovation Platform		6.16	2.18	5.73	0.77	0.77	5.12	0.31	20.66	0.02	10.44	0.01	28.39	20.14	0.12	0.16	0.14	2.24	5.12	0.18	25.23	0.20	0.20	0.27	0.73	0.33	0.12	0.40	NA
Active Pharmaceutical Ingredient Sales		NA	NA	NA	0.58	0.41	0.73	0.99	1.87	1.05	0.30	1.23	1.02	0.42	3.65	3.83	4.83	8.41	3.69	3.21	2.64	4.98	5.34	2.02	3.00	3.59	4.05	3.73	NA
Commercial Product Sales		4.03	30.68	25.35	27.93	22.84	25.89	19.97	18.06	20.72	24.48	38.88	17.50	13.67	15.50	18.16	20.08	10.55	8.28	7.68	9.14	8.10	7.50	1.91	0.13	0.18	0.02	0.03	NA
Contract Manufacturing Revenue		1.35	0.67	0.44	0.44	0.24	0.42	0.43	0.43	0.01	-0.00	0.06	0.02	0.01	0.09	0.04	0.25	0.05	0.02	0.15	0.24	0.43	0.25	0.25	0.44	0.27	0.52	0.54	NA
License And Other Revenue		3.25	2.18	5.73	0.77	1.45	5.26	0.54	20.66	0.03	10.70	0.01	28.39	20.26	0.13	0.16	0.14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
License		3.25	2.17	5.72	0.77	0.76	5.11	0.30	20.50	0.01	10.43	0.00	28.38	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		5.38	31.35	25.79	28.95	23.48	27.04	21.39	20.36	21.78	24.78	40.17	18.55	14.10	19.24	22.03	25.16	19.01	13.31	11.47	12.61	14.13	13.66	4.42	3.90	NA	NA	NA	NA
Product And Service Other		0.01	0.01	0.01	0.01	0.69	0.15	0.24	0.17	0.02	0.26	0.01	0.01	0.16	0.13	0.16	0.14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Commercial Platform, Transferred At Point In Time		NA	24.87	19.94	22.71	16.91	21.03	15.79	13.26	16.09	21.73	36.21	15.54	12.15	12.01	11.60	14.68	7.42	7.32	7.00	8.69	7.94	7.38	1.82	0.08	NA	NA	NA	NA
Global Supply Chain Platform, Transferred At Point In Time		NA	6.48	5.84	6.24	7.25	6.14	5.83	7.10	5.70	3.31	3.95	3.01	2.07	7.24	10.44	10.49	11.61	6.00	4.38	3.91	6.73	6.41	2.50	3.77	NA	NA	NA	NA
Oncology Innovation Platform, Transferred At Point In Time		NA	2.18	5.73	0.77	0.77	5.12	0.31	20.66	0.02	10.44	0.01	28.39	20.14	0.12	0.16	0.14	2.24	5.12	0.18	25.23	0.20	0.20	0.27	0.73	NA	NA	NA	NA
		NA	NA	NA	0.59	1.49	0.32	0.65	0.20	0.20	10.96	0.12	28.51	0.27	0.56	0.89	0.39	2.50	0.31	0.96	0.65	1.04	1.04	0.42	0.31	0.71	0.52	0.66	NA
US		1.91	33.52	31.51	29.14	23.74	31.39	20.68	38.65	20.72	18.12	26.00	17.52	13.68	15.62	18.16	20.34	10.50	9.56	7.94	9.90	8.88	8.11	2.23	0.71	1.00	1.06	1.01	NA
Other Foreign Countries Including Austria		NA	0.01	0.01	NA	0.15	0.14	0.15	2.17	0.24	0.03	0.05	0.90	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Non Us		1.99	0.01	0.01	NA	-0.01	0.14	0.15	2.17	0.04	0.03	0.02	0.90	1.53	0.11	0.77	0.61	2.05	1.08	0.55	0.08	-0.03	0.86	0.45	0.58	0.47	0.36	0.48	NA
, Global Supply Chain Platform, Transferred At Point In Time		NA	NA	NA	0.58	1.48	0.31	0.64	0.20	0.19	0.52	0.12	0.20	0.13	0.45	0.73	0.24	0.26	0.19	0.78	0.42	0.83	0.83	0.15	NA	NA	NA	NA	NA
, Oncology Innovation Platform, Transferred At Point In Time		NA	NA	NA	0.01	0.01	0.01	0.01	0.01	0.01	10.44	0.01	28.31	0.14	0.12	0.16	0.14	2.24	0.12	0.18	0.23	0.20	0.20	0.27	NA	NA	NA	NA	NA
US, Commercial Platform, Transferred At Point In Time		NA	24.87	19.94	22.71	16.91	21.03	15.79	13.26	16.09	15.37	23.28	15.54	12.15	12.01	11.60	14.68	7.42	7.32	7.00	8.69	7.94	7.38	1.82	NA	NA	NA	NA	NA
US, Global Supply Chain Platform, Transferred At Point In Time		NA	6.48	5.84	5.66	6.16	5.27	4.60	5.23	4.63	2.75	2.72	1.98	1.53	3.62	6.56	5.66	3.08	2.24	0.95	1.21	0.93	0.74	0.41	NA	NA	NA	NA	NA
US, Oncology Innovation Platform, Transferred At Point In Time		NA	2.17	5.72	0.77	0.67	5.09	0.29	20.16	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Foreign Countries Including Austria, Oncology Innovation Platform, Transferred At Point In Time		NA	0.01	0.01	NA	0.10	0.02	0.01	0.50	0.01	0.00	0.00	0.08	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Royalty		NA	0.40	0.60	0.60	NA	0.10	0.20	0.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept